Literature DB >> 27448308

Breast cancer epidemic in the early twenty-first century: evaluation of risk factors, cumulative questionnaires and recommendations for preventive measures.

Olga Golubnitschaja1,2, Manuel Debald3,4, Kristina Yeghiazaryan3,5, Walther Kuhn3,4, Martin Pešta6,7, Vincenzo Costigliola8, Godfrey Grech9.   

Abstract

Rapidly increasing incidence of breast cancer is a new social challenge resulting from a spectrum of internal and external risk factors which appear to be well accepted as an attribute of the early twenty-first century, being, however, new for female sub-populations compared to the past. These include altered socio-economical conditions such as occupational exposure, rotating shift work, specific environmental factors (increased pollution and environmental toxicity, altered dietary habits, quality and composition of meal) as well as consequently shifted and/or adapted physiologic factors such as lower age at menarche, late age of first full-term pregnancy, if any, shorter periods of breastfeeding and later menopause. Consolidated expert statements suggest that over 50 % of all breast cancer cases may be potentially prevented by risk reduction strategy such as regulation of modifiable risk factors. Currently available risk assessment models may estimate potential breast cancer predisposition, in general; however, they are not able to predict the disease manifestation individually. Further, current deficits in risk assessment and effective breast cancer prevention have been recently investigated and summarised as follows: gaps in risk estimation, preventive therapy, lifestyle prevention, understanding of the biology of breast cancer risk and implementation of known preventive measures. This paper overviews the most relevant risk factors, provides recommendations for improved risk assessment and proposes an extended questionnaire for effective preventive measures.

Entities:  

Keywords:  Breast cancer; Epidemic; Individualised patient profile; Predictive preventive personalised medicine; Questionnaire

Mesh:

Year:  2016        PMID: 27448308     DOI: 10.1007/s13277-016-5168-x

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  183 in total

1.  Associations between physical activity and other health behaviors in a representative sample of US adolescents.

Authors:  R R Pate; G W Heath; M Dowda; S G Trost
Journal:  Am J Public Health       Date:  1996-11       Impact factor: 9.308

2.  Risk of breast cancer in female flight attendants: a population-based study (Iceland).

Authors:  V Rafnsson; H Tulinius; J G Jónasson; J Hrafnkelsson
Journal:  Cancer Causes Control       Date:  2001-02       Impact factor: 2.506

Review 3.  Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focus.

Authors:  G A Colditz; A L Frazier
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1995 Jul-Aug       Impact factor: 4.254

4.  Lead exposure: a contributing cause of the current breast cancer epidemic in Nigerian women.

Authors:  Olusegun I Alatise; Gerhard N Schrauzer
Journal:  Biol Trace Elem Res       Date:  2010-03-03       Impact factor: 3.738

5.  Circulating hormones and breast cancer risk in premenopausal women: a randomized trial of low-dose tamoxifen and fenretinide.

Authors:  Harriet Johansson; Bernardo Bonanni; Sara Gandini; Aliana Guerrieri-Gonzaga; Massimiliano Cazzaniga; Davide Serrano; Debora Macis; Antonella Puccio; Maria Teresa Sandri; Marcella Gulisano; Franca Formelli; Andrea Decensi
Journal:  Breast Cancer Res Treat       Date:  2013-11-17       Impact factor: 4.872

Review 6.  Behavioral symptoms in patients with breast cancer and survivors.

Authors:  Julienne E Bower
Journal:  J Clin Oncol       Date:  2008-02-10       Impact factor: 44.544

7.  Recommendations for the prevention of breast cancer in shift workers.

Authors:  Kneginja Richter; Jens Acker; Nikola Kamcev; Stojan Bajraktarov; Anja Piehl; Guenter Niklewski
Journal:  EPMA J       Date:  2011-12-23       Impact factor: 6.543

8.  Cancer predisposition in diabetics: risk factors considered for predictive diagnostics and targeted preventive measures.

Authors:  Melanie Cebioglu; Hans H Schild; Olga Golubnitschaja
Journal:  EPMA J       Date:  2010-03-11       Impact factor: 6.543

Review 9.  Inflammatory bowel disease: an expanding global health problem.

Authors:  Amosy E M'Koma
Journal:  Clin Med Insights Gastroenterol       Date:  2013-08-14

10.  Cancer screening among a population-based sample of insured women.

Authors:  Sharon Hensley Alford; Steven Leadbetter; Juan L Rodriguez; Nikki A Hawkins; Lawrence E Scholl; Lucy A Peipins
Journal:  Prev Med Rep       Date:  2014-11-28
View more
  40 in total

1.  Effect of luteolin on the methylation status of the OPCML gene and cell growth in breast cancer cells.

Authors:  Xinmin Dong; Jian Zhang; Fan Yang; Jing Wu; Rui Cai; Tian Wang; Jiren Zhang
Journal:  Exp Ther Med       Date:  2018-07-26       Impact factor: 2.447

Review 2.  Plant natural modulators in breast cancer prevention: status quo and future perspectives reinforced by predictive, preventive, and personalized medical approach.

Authors:  Sona Uramova; Peter Kubatka; Zuzana Dankova; Andrea Kapinova; Barbora Zolakova; Marek Samec; Pavol Zubor; Anthony Zulli; Vanda Valentova; Taeg Kyu Kwon; Peter Solar; Martin Kello; Karol Kajo; Dietrich Busselberg; Martin Pec; Jan Danko
Journal:  EPMA J       Date:  2018-11-12       Impact factor: 6.543

Review 3.  Impaired wound healing: facts and hypotheses for multi-professional considerations in predictive, preventive and personalised medicine.

Authors:  Eden Avishai; Kristina Yeghiazaryan; Olga Golubnitschaja
Journal:  EPMA J       Date:  2017-03-03       Impact factor: 6.543

Review 4.  Feeling cold and other underestimated symptoms in breast cancer: anecdotes or individual profiles for advanced patient stratification?

Authors:  Olga Golubnitschaja
Journal:  EPMA J       Date:  2017-03-08       Impact factor: 6.543

Review 5.  Pregnancy-associated breast cancer: the risky status quo and new concepts of predictive medicine.

Authors:  Jiri Polivka; Irem Altun; Olga Golubnitschaja
Journal:  EPMA J       Date:  2018-02-08       Impact factor: 6.543

6.  Postmenopausal breast cancer: European challenge and innovative concepts.

Authors:  Ivica Smokovski; Milan Risteski; Jiri Polivka; Pavol Zubor; Katarzyna Konieczka; Vincenzo Costigliola; Olga Golubnitschaja
Journal:  EPMA J       Date:  2017-05-30       Impact factor: 6.543

Review 7.  Mystery of the brain metastatic disease in breast cancer patients: improved patient stratification, disease prediction and targeted prevention on the horizon?

Authors:  Jiri Polivka; Milena Kralickova; Jiri Polivka; Christina Kaiser; Walther Kuhn; Olga Golubnitschaja
Journal:  EPMA J       Date:  2017-03-13       Impact factor: 6.543

8.  Breast cancer and Flammer syndrome: any symptoms in common for prediction, prevention and personalised medical approach?

Authors:  Pavol Zubor; Alexandra Gondova; Jiri Polivka; Petra Kasajova; Katarzyna Konieczka; Jan Danko; Olga Golubnitschaja
Journal:  EPMA J       Date:  2017-04-10       Impact factor: 6.543

9.  MicroRNA-433 targets AKT3 and inhibits cell proliferation and viability in breast cancer.

Authors:  Xiaolei Hu; Jie Wang; Wan He; Pan Zhao; Changsheng Ye
Journal:  Oncol Lett       Date:  2018-01-16       Impact factor: 2.967

Review 10.  Liver metastatic disease: new concepts and biomarker panels to improve individual outcomes.

Authors:  Olga Golubnitschaja; Krishna Chander Sridhar
Journal:  Clin Exp Metastasis       Date:  2016-08-19       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.